We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New Guidelines on MRI Safety and Compatibility of Medical Devices

By HospiMedica International staff writers
Posted on 13 Jan 2015
The US Food and Drug Administration issued new guidance recommendations on magnetic resonance imaging (MRI) compatibility—or in some instances, incompatibility—of implants that do not require electricity to service their function, such as intracranial aneurysm clips, cardiovascular stents, endovascular grafts, and transprostatic tissue retractors.

The topic of MRI-safe devices, up to now, has mostly centered on devices such as pacemakers, and more recently cochlear implants, both of which use electronics. More...
Now, however, the FDA (Silver Spring, MD, USA) has three principal concerns about patient safety in regards to these so-called “passive” implants in the MRI setting: the displacement forces and torques on magnetic substances, which can turn devices into deadly projectiles; radiofrequency heating that can burn patients; and the distorting effect of implants upon an MRI scan. The FDA recommends four tests described by standard setting institution, American Society for Testing and Materials (ASTM) International, to tackle these three safety issues, and provides additional details about the way those tests should be performed. For example, the guidance reported that “the testing should encompass the range of sizes of the device you intend to market.”

MRI scans are provided in various magnetic field strengths, measured in Teslas. “Although commercial 1.5 T MR systems are currently the most common, 3 T MR systems are becoming more common. A medical device that is classified as MR Conditional in a 1.5 T scanner may not be safe to scan in an MR system with a higher or lower field strength,” the guidance cautioned.

The implant’s labeling should describe the device as “MR Safe,” “MR Unsafe,” or “MR Conditional,” as defined by ASTM International in standard F2503-13. Lastly, the fourth category, “Safety in MRI Not Evaluated,” may be suitable in some instances, but not for those passive implants that are known to present MRI compatibility issues, are a new device type or contain ferromagnetic materials.

Related Links:

US Food and Drug Administration



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.